Toyonori Tsuzuki
Aichi Medical University
297 Papers
616 Citations
Toyonori Tsuzuki is an academic researcher from Aichi Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 30, co-authored 207 publications.
Chat about Author
Papers
Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate.
Akiyuki Yamamoto,Masashi Kato,Hirotaka Matsui,Ryo Ishida,Tohru Kimura,Yasuhito Funahashi,Naoto Sassa,Yoshihisa Matsukawa,Osamu Kamihira,Ryohei Hattori,Momokazu Gotoh,Toyonori Tsuzuki +11 more
TL;DR: The presence of IDC-P is an independent prognostic factor in CRPC patients with distant metastases and IDC -P in needle biopsies at the time of initial diagnosis, and docetaxel may prolong CSS and OS.
Prognostic parameter for high risk prostate cancer patients at initial presentation.
Masashi Kato,Kyosuke Kimura,Akihiro Hirakawa,Yumiko Kobayashi,Ryo Ishida,Osamu Kamihira,Tsuyoshi Majima,Yasuhito Funahashi,Naoto Sassa,Yoshihisa Matsukawa,Ryohei Hattori,Momokazu Gotoh,Toyonori Tsuzuki +12 more
TL;DR: This study evaluated whether intraductal carcinoma of the prostate (IDC‐P) confirmed by needle biopsy is an adverse prognostic parameter for progression‐free survival (PFS) and cancer‐specific survival (CSS) in patients with high‐risk prostate cancer.
Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma.
Tomoya Mizuno,Takao Kamai,Toyonori Tsuzuki,Daisaku Nishihara,Toshiki Kijima,Kyoko Arai,Ken-Ichiro Yoshida +6 more
TL;DR: In this paper, the authors measured the immunohistochemical expression of B7-H4, CD8 and T cell intracellular antigen 1 (TIA-1), a marker of activated CD8, in 133 patients with upper urinary tract urothelial carcinoma (UTUC) who underwent nephroureterectomy.
Response of intraductal carcinoma of the prostate to androgen deprivation therapy predicts prostate cancer prognosis in radical prostatectomy patients.
Masashi Kato,Akihiro Hirakawa,Yumiko Kobayashi,Akiyuki Yamamoto,Ryo Ishida,Osamu Kamihira,Tomoyasu Sano,Tsuyoshi Majima,Shohei Ishida,Yasuhito Funahashi,Naoto Sassa,Takashi Fujita,Yoshihisa Matsukawa,Ryohei Hattori,Momokazu Gotoh,Toyonori Tsuzuki +15 more
TL;DR: Intraductal carcinoma of the prostate (IDC‐P) has a poor prognosis and is thought to be completely resistant to current therapies, including androgen deprivation therapy (ADT), but there is no data showing direct evidence of such resistance.
Case of primary central nervous system histiocytic sarcoma with prominent proliferation of histiocytic cells between the trabeculae of reactive glial cells.
TL;DR: This is the first reported case of HS with prominent proliferation of the histiocytic cells between the trabeculae of reactive glial cells, and the detailed histological, immunohistochemical, and molecular findings are presented.